Kobayashi Pharmaceutical Co., Ltd. (TSE:4967) agreed to acquire Meitanhonpo.Co.,Ltd. on March 28, 2019. Post completion, Meitanhonpo become a subsidiary of Kobayashi Pharmaceutical Co., Ltd. Kobayashi Pharmaceutical Co., Ltd. (TSE:4967) completed the acquisition of Meitanhonpo.Co.,Ltd. on May 14, 2019.